Cargando…

Evaluation of the performance of 25 SARS-CoV-2 serological rapid diagnostic tests using a reference panel of plasma specimens at the Uganda Virus Research Institute

INTRODUCTION: Serological testing is needed to better understand the epidemiology of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. Rapid diagnostic tests (RDTs) have been developed to detect specific antibodies, IgM and IgG, to the virus. The performance of 25 of these RDTs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lutalo, Tom, Nalumansi, Aminah, Olara, Denis, Kayiwa, John, Ogwang, Bernard, Odwilo, Emmanuel, Watera, Christine, Balinandi, Stephen, Kiconco, Jocelyn, Nakaseegu, Joweria, Serwanga, Jennifer, Kikaire, Bernard, Ssemwanga, Deogratius, Abiko, Brendah, Nsereko, Christopher, Cotten, Matthew, Buule, Joshua, Lutwama, Julius, Downing, Robert, Kaleebu, Pontiano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442260/ https://www.ncbi.nlm.nih.gov/pubmed/34536612 http://dx.doi.org/10.1016/j.ijid.2021.09.020

Ejemplares similares

Field evaluation of the performance of a SARS-CoV-2 antigen rapid diagnostic test in Uganda using nasopharyngeal samples
por: Nalumansi, Aminah, et al.
Publicado: (2021)

Main Routes of Entry and Genomic Diversity of SARS-CoV-2, Uganda
por: Bugembe, Daniel Lule, et al.
Publicado: (2020)

Short Communication: Choosing the Right Program for the Identification of HIV-1 Transmission Networks from Nucleotide Sequences Sampled from Different Populations
por: Bbosa, Nicholas, et al.
Publicado: (2020)

Field evaluation of the performance of seven Antigen Rapid diagnostic tests for the diagnosis of SARs-CoV-2 virus infection in Uganda
por: Bwogi, Josephine, et al.
Publicado: (2022)

Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 months
por: Serwanga, Jennifer, et al.
Publicado: (2023)

Rapid Replacement of SARS-CoV-2 Variants by Delta and Subsequent Arrival of Omicron, Uganda, 2021
por: Bbosa, Nicholas, et al.
Publicado: (2022)

Evaluation of HIV-1 rapid tests and identification of alternative testing algorithms for use in Uganda
por: Kaleebu, Pontiano, et al.
Publicado: (2018)

HIV drug resistance among adults initiating antiretroviral therapy in Uganda
por: Watera, Christine, et al.
Publicado: (2021)

Differential Performance of CoronaCHEK SARS-CoV-2 Lateral Flow Antibody Assay by Geographic Origin of Samples
por: Baker, Owen R., et al.
Publicado: (2021)

Epidemiology, Clinical Characteristics, and Mortality of Hospitalized Patients with Severe COVID-19 in Uganda, 2020–2021
por: Bakamutumaho, Barnabas, et al.
Publicado: (2022)

Phylogenetic Networks and Parameters Inferred from HIV Nucleotide Sequences of High-Risk and General Population Groups in Uganda: Implications for Epidemic Control
por: Bbosa, Nicholas, et al.
Publicado: (2021)

Prevalence of viral load suppression, predictors of virological failure and patterns of HIV drug resistance after 12 and 48 months on first-line antiretroviral therapy: a national cross-sectional survey in Uganda
por: Ssemwanga, Deogratius, et al.
Publicado: (2020)

Host HLA B*Allele-Associated Multi-Clade Gag T-Cell Recognition Correlates with Slow HIV-1 Disease Progression in Antiretroviral Therapy-Naïve Ugandans
por: Serwanga, Jennifer, et al.
Publicado: (2009)

Population-based monitoring of HIV drug resistance early warning indicators in Uganda: A nationally representative survey following revised WHO recommendations
por: Asio, Juliet, et al.
Publicado: (2020)

Optimisation and Validation of a conventional ELISA and cut-offs for detecting and quantifying anti-SARS-CoV-2 Spike, RBD, and Nucleoprotein IgG, IgM, and IgA antibodies in Uganda
por: Oluka, Gerald Kevin, et al.
Publicado: (2023)

Multiple HIV-1 infections with evidence of recombination in heterosexual partnerships in a low risk Rural Clinical Cohort in Uganda
por: Ssemwanga, Deogratius, et al.
Publicado: (2011)

QuasiFlow: a Nextflow pipeline for analysis of NGS-based HIV-1 drug resistance data
por: Ssekagiri, Alfred, et al.
Publicado: (2022)

Effect of HIV-1 Subtypes on Disease Progression in Rural Uganda: A Prospective Clinical Cohort Study
por: Ssemwanga, Deogratius, et al.
Publicado: (2013)

Analysis of the history and spread of HIV-1 in Uganda using phylodynamics
por: Yebra, Gonzalo, et al.
Publicado: (2015)

HIV-1 drug resistance genotyping success rates and correlates of Dried-blood spots and plasma specimen genotyping failure in a resource-limited setting
por: Omooja, Jonah, et al.
Publicado: (2022)

The viral aetiology of influenza-like illnesses in Kampala and Entebbe, Uganda, 2008
por: Balinandi, Stephen, et al.
Publicado: (2013)

Phylogeography of HIV-1 suggests that Ugandan fishing communities are a sink for, not a source of, virus from general populations
por: Bbosa, Nicholas, et al.
Publicado: (2019)

Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy
por: Serwanga, Jennifer, et al.
Publicado: (2023)

Frequencies of Gag-restricted T-cell escape “footprints” differ across HIV-1 clades A1 and D chronically infected Ugandans irrespective of host HLA B alleles()
por: Serwanga, Jennifer, et al.
Publicado: (2015)

Computational MHC-I epitope predictor identifies 95% of experimentally mapped HIV-1 clade A and D epitopes in a Ugandan cohort
por: Bugembe, Daniel Lule, et al.
Publicado: (2020)

Alternate primers for whole-genome SARS-CoV-2 sequencing
por: Cotten, Matthew, et al.
Publicado: (2021)

Phylogenetic and Demographic Characterization of Directed HIV-1 Transmission Using Deep Sequences from High-Risk and General Population Cohorts/Groups in Uganda
por: Bbosa, Nicholas, et al.
Publicado: (2020)

A large population sample of African HIV genomes from the 1980s reveals a reduction in subtype D over time associated with propensity for CXCR4 tropism
por: Grant, Heather E., et al.
Publicado: (2022)

Severe COVID-19 in Uganda across Two Epidemic Phases: A Prospective Cohort Study
por: Bakamutumaho, Barnabas, et al.
Publicado: (2021)

Infection with HIV-1 subtype D among acutely infected Ugandans is associated with higher median concentration of cytokines compared to subtype A
por: Kapaata, Anne, et al.
Publicado: (2022)

The Molecular Epidemiology and Transmission Dynamics of HIV Type 1 in a General Population Cohort in Uganda
por: Ssemwanga, Deogratius, et al.
Publicado: (2020)

Sustained virological response and drug resistance among female sex workers living with HIV on antiretroviral therapy in Kampala, Uganda: a cross-sectional study
por: Namale, Gertrude, et al.
Publicado: (2019)

Employing phylogenetic tree shape statistics to resolve the underlying host population structure
por: Kayondo, Hassan W., et al.
Publicado: (2021)

Interferon gamma (IFN-γ) negative CD4+ and CD8+ T-cells can produce immune mediators in response to viral antigens
por: Nakiboneka, Ritah, et al.
Publicado: (2019)

Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial
por: Gombe, Ben, et al.
Publicado: (2022)

Vaccination against SARS-CoV-2 in a rural Ugandan population
por: Mugisha, Joseph, et al.
Publicado: (2023)

Rates of HIV-1 virological suppression and patterns of acquired drug resistance among fisherfolk on first-line antiretroviral therapy in Uganda
por: Omooja, Jonah, et al.
Publicado: (2019)

CD8(+) T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4(+) T Cells <200 Cell/μL: The DART Trial STI Substudy
por: Serwanga, Jennifer, et al.
Publicado: (2011)

HIV-1 transmission networks in high risk fishing communities on the shores of Lake Victoria in Uganda: A phylogenetic and epidemiological approach
por: Kiwuwa-Muyingo, Sylvia, et al.
Publicado: (2017)

Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda
por: Kaleebu, Pontiano, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6put2n1q8ompctur04lc6ot3k0